Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iván Cervigón

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Dermatology Online Journal|August 4, 2011
Effectiveness of bosentan in the treatment of ischemic lesions in a case of thromboangiitis obliterans (Buerger disease): a case reportAngel Palomo-Arellano, Iván Cervigón-González, Luis Miguel Torres-Iglesias
Case Reports in Dermatology|September 21, 2011
Advanced-stage primary cutaneous T-cell lymphoma treated with bexarotene and denileukin diftitoxIván Cervigón-González, Luis Miguel Torres-Iglesias, Angel Palomo-Arellano, et al.
Actas Dermo-Sifiliograficas|October 28, 2006
[Alopecia mucinosa]Iván Cervigón-González, Francisco Javier Manzanares, Constanza Bahillo, et al.
Actas Dermo-Sifiliograficas|June 28, 2006
[Merkel cell carcinoma in a patient with chronic lymphocytic leukemia]Iván Cervigón, Ana B Gargallo, Constanza Bahillo, et al.
JAMA Dermatology|November 14, 2018
Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With BexaroteneIrene Cabello, Pedro Alia, Xavier Pintó, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Dermatology Online Journal|August 4, 2011
Effectiveness of bosentan in the treatment of ischemic lesions in a case of thromboangiitis obliterans (Buerger disease): a case reportAngel Palomo-Arellano, Iván Cervigón-González, Luis Miguel Torres-Iglesias
Case Reports in Dermatology|September 21, 2011
Advanced-stage primary cutaneous T-cell lymphoma treated with bexarotene and denileukin diftitoxIván Cervigón-González, Luis Miguel Torres-Iglesias, Angel Palomo-Arellano, et al.
Actas Dermo-Sifiliograficas|October 28, 2006
[Alopecia mucinosa]Iván Cervigón-González, Francisco Javier Manzanares, Constanza Bahillo, et al.
Actas Dermo-Sifiliograficas|June 28, 2006
[Merkel cell carcinoma in a patient with chronic lymphocytic leukemia]Iván Cervigón, Ana B Gargallo, Constanza Bahillo, et al.
JAMA Dermatology|November 14, 2018
Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With BexaroteneIrene Cabello, Pedro Alia, Xavier Pintó, et al.
Pageof 1